Drug Eruptions: Clinical Trials

3 trials for Drug Eruptions, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 22Completed 2

Follow Drug Eruptions: new trials by email Literature Review of Drug Eruptions trials Research Report on Drug Eruptions

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Riboflavin - Chemical Injuries, Unspecified Complication of Corneal Transplant
Phase 1 / Phase 2CompletedJoseph B. Ciolino, MD12012-03-012019-10-21
Treatment of Palmar Plantar Erythrodysesthesia (PPE) With Topical Sildenafil
sildenafil citrate - Hand Foot Syndrome, Palmar Plantar Erythrodysesthesia
Phase 1CompletedDuke University102010-06-012012-10-30
Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome
Cream, 0.1% Uracil Cream - Palmar-Plantar Erythrodysesthesia, Breast Cancer
Phase 1 / Phase 2CompletedNanometics (d.b.a. PHD Biosciences)182010-04-012019-10-08

Narrower conditions

Hand-Foot Syndrome (2)  ·  Arthritis, Rheumatoid (1)  ·  Autoimmune Diseases (1)  ·  Breast Neoplasms (1)  ·  Hyaline Fibromatosis Syndrome (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Pemphigoid, Benign Mucous Membrane (1)  ·  Stevens-Johnson Syndrome (1)

Broader conditions

Chemically-Induced Disorders (3)  ·  Dermatitis (3)  ·  Drug Hypersensitivity (3)  ·  Drug-Related Side Effects and Adverse Reactions (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Arthritis (1)  ·  Breast Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Conjunctival Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Erythema (1)  ·  Erythema Multiforme (1)  ·  Eye Diseases (1)

Interventions

Riboflavin (1)  ·  Sildenafil Citrate (1)  ·  Solutions (1)

Sponsors

Duke University (1)  ·  Joseph B. Ciolino, MD (1)  ·  Nanometics (d.b.a. PHD Biosciences) (1)

Countries

United States (3)

Top investigators

Herbert Hurwitz, MD (1)  ·  James Cantrell, MD (1)  ·  Joseph Ciolino, MD (1)